The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Staiger, Wilko I ^a   Ronellenfitsch, Ulrich ^a   Kaehler, Georg ^a   Schildhaus, Hans ^b   Dimitrakopoulou Strauss, Antonia ^c   Schwarzbach, Matthias H M ^a   Hohenberger, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMATINIB; LOPERAMIDE; METOCLOPRAMIDE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; ESOPHAGUS ULCER; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MALE; MERENDINO PROCEDURE; NAUSEA; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SPLENECTOMY; STOMACH ULCER; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TUMOR REGRESSION; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; ESOPHAGOGASTRIC JUNCTION; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 42449113421     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-37     Document Type: Article

References (29)

1. Coindre JM Emile JF Monges G Ranchere-Vince D Scoazec JY Gastrointestinal stromal tumors: Definition, histological, immunohistochemical, and molecular features, and diagnostic strategy Ann Pathol 2005, 25:358-385. quiz 357 10.1016/S0242-6498(05)80145-2 16498290
2. Hirota S Isozaki K Pathology of gastrointestinal stromal tumors Pathol Int 2006, 56:1-9. 10.1111/j.1440-1827.2006.02036.x 16398673
3. Nilsson B Bumming P Meis-Kindblom JM Oden A Dortok A Gustavsson B Sablinska K Kindblom LG Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden Cancer 2005, 103:821-829. 10.1002/cncr.20862 15648083
4. Tran T Davila JA El-Serag HB The epidemiology of malignant gastrointestinal stromal tumors: An analysis of 1,458 cases from 1992 to 2000 Am J Gastroenterol 2005, 100:162-168. 10.1111/ j.1572-0241.2005.40709.x 15654796
5. Reichardt P Pink D Mrozek A Lindner T Hohenberger P Gastrointestinal stromal tumors (GIST) Z Gastroenterol 2004, 42:327-331. 10.1055/ s-2004-812691 15095124
6. Raut CP Posner M Desai J Morgan JA George S Zahrieh D Fletcher CD Demetri GD Bertagnolli MM Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors J Clin Oncol 2006, 24:2325-2331. 10.1200/ JCO.2005.05.3439 16710031
7. Perez EA Livingstone AS Franceschi D Rocha-Lima C Lee DJ Hodgson N Jorda M Koniaris LG Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors J Am Coll Surg 2006, 202:623-629. 10.1016/j.jamcollsurg.2006.01.002 16571433
8. Demetri GD von Mehren M Blanke CD Van den Abbeele AD Eisenberg B Roberts PJ Heinrich MC Tuveson DA Singer S Janicek M Fletcher JA Silverman SG Silberman SL Capdeville R Kiese B Peng B Dimitrijevic S Druker BJ Corless C Fletcher CD Joensuu H Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 2002, 347:472-480. 10.1056/NEJMoa020461 12181401
9. Miettinen M Lasota J Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics Pol J Pathol 2003, 54:3-24. 12817876
10. Emory TS Sobin LH Lukes L Lee DH O'Leary TJ Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site Am J Surg Pathol 1999, 23:82-87. 10.1097/00000478-199901000-00009 9888707
11. Blum MG Bilimoria KY Wayne JD de Hoyos AL Talamonti MS Adley B Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors Ann Thorac Surg 2007, 84:1717-1723. 10.1016/j.athoracsur.2007.05.071 17954092
12. Miettinen M Sarlomo-Rikala M Sobin LH Lasota J Esophageal stromal tumors: A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas Am J Surg Pathol 2000, 24:211-222. 10.1097/ 00000478-200002000-00007 10680889
13. Hirota S Isozaki K Moriyama Y Hashimoto K Nishida T Ishiguro S Kawano K Hanada M Kurata A Takeda M Muhammad Tunio G Matsuzawa Y Kanakura Y Shinomura Y Kitamura Y Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 1998, 279:577-580. 10.1126/ science.279.5350.577 9438854
14. Miettinen M Lasota J Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis Arch Pathol Lab Med 2006, 130:1466-1478. 17090188
15. Fletcher CD Berman JJ Corless C Gorstein F Lasota J Longley BJ Miettinen M O'Leary TJ Remotti H Rubin BP Shmookler B Sobin LH Weiss SW Diagnosis of gastrointestinal stromal tumors: A consensus approach Hum Pathol 2002, 33:459-465. 10.1053/hupa.2002.123545 12094370
16. Novitsky YW Kercher KW Sing RF Heniford BT Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors Ann Surg 2006, 243:738-745. discussion 745-7 1570564 16772777 10.1097/ 01.sla.0000219739.11758.27
17. Hohenberger P Reichardt P Gebauer B Wardelmann E Gastrointestinal stromal tumors (GIST) - current concepts of surgical management Dtsch Med Wochenschr 2004, 129:1817-1820. 10.1055/s-2004-829035 15314746
18. NCCN guidelines http://www.nccn.org/professionals/physician_gls/PDF/ sarcoma.pdf
19. Hohenberger P Wardelmann E Surgical considerations for gastrointestinal stroma tumor Chirurg 2006, 77:33-40. 10.1007/s00104-005-1125-8 16372188
20. Gockel I Pietzka S Junginger T Quality of life after subtotal resection and gastrectomy for gastric cancer Chirurg 2005, 76:250-257. 10.1007/ s00104-004-0950-5 15551010
21. Merendino KA Dillard DH The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices Ann Surg 1955, 142:486-506. 1465090 13249345
22. Stein HJ Feith M Mueller J Werner M Siewert JR Limited resection for early adenocarcinoma in Barrett's esophagus Ann Surg 2000, 232:733-742. 1421266 11088068 10.1097/00000658-200012000-00002
23. Rutkowski P Nowecki Z Nyckowski P Dziewirski W Grzesiakowska U Nasierowska-Guttmejer A Krawczyk M Ruka W Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate J Surg Oncol 2006, 93:304-311. 10.1002/jso.20466 16496358
24. Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L Verweij J Van Glabbeke M van Oosterom AT Christian MC Gwyther SG New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 2000, 92:205-216. 10.1093/jnci/92.3.205 10655437
25. Verweij J Casali PG Zalcberg J LeCesne A Reichardt P Blay JY Issels R van Oosterom A Hogendoorn PC Van Glabbeke M Bertulli R Judson I Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomised trial Lancet 2004, 364:1127-1134. 10.1016/ S0140-6736(04)17098-0 15451219
26. Stroszczynski C Jost D Reichardt P Chmelik P Gaffke G Kretzschmar A Schneider U Felix R Hohenberger P Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI Eur Radiol 2005, 15:2448-2456. 10.1007/s00330-005-2867-x 16132930
27. Choi H Charnsangavej C de Castro Faria S Tamm EP Benjamin RS Johnson MM Macapinlac HA Podoloff DA CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings AJR Am J Roentgenol 2004, 183:1619-1628. 15547201
28. Stroobants S Goeminne J Seegers M Dimitrijevic S Dupont P Nuyts J Martens M van den Borne B Cole P Sciot R Dumez H Silberman S Mortelmans L van Oosterom A 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec) Eur J Cancer 2003, 39:2012-2020. 10.1016/ S0959-8049(03)00073-X 12957455
29. Ott K Weber WA Lordick F Becker K Busch R Herrmann K Wieder H Fink U Schwaiger M Siewert JR Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction J Clin Oncol 2006, 24:4692-4698. 10.1200/JCO.2006.06.7801 16966684